STOCK TITAN
  1. Home
  2. Sec-filings
  3. AGEN
  4. [SCHEDULE 13G/A] Agenus Inc. SEC Filing

[SCHEDULE 13G/A] Agenus Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock AGEN logo
Agenus

NASDAQ:AGEN

AGEN Rankings

#7849 Ranked by Market Cap
N/A Ranked by Dividends
#119 Top Gainer

AGEN Latest News

Jul 17, 2025
US FDA Approves GSK’s SHINGRIX in a Prefilled Syringe Presentation
Jul 7, 2025
Agenus’ BOT/BAL Achieves 42% Two-Year Survival in Refractory MSS CRC, Advances Toward Registration with FDA Alignment on Phase 3
Jun 17, 2025
Agenus and Noetik Enter Collaboration to Develop AI-Enabled Predictive Biomarkers for BOT/BAL Using Foundation Models of Virtual Cell Biology
Jun 10, 2025
Agenus Announces Virtual Annual Shareholders Meeting
Jun 3, 2025
Zydus to enter global biologics CDMO business: Plans to acquire Agenus' U.S. manufacturing facilities to accelerate development of innovative therapies

AGEN Latest SEC Filings

Jul 15, 2025
[Form 4] Agenus Inc. Insider Trading Activity
Jul 15, 2025
[Form 4] Agenus Inc. Insider Trading Activity
Jul 3, 2025
[Form 4] Agenus Inc. Insider Trading Activity
Jun 30, 2025
[Form 4] Agenus Inc. Insider Trading Activity
Jun 30, 2025
[Form 4] Agenus Inc. Insider Trading Activity

AGEN Stock Data

133.25M
26.89M
1.31%
33.81%
13.66%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
LEXINGTON